OCUL
USDOcular Therapeutix Inc. Common Stock
$8.820-0.180 (-2.000%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$9.000
High
$9.183
Low
$8.719
Volume
0.17M
Company Fundamentals
Market Cap
1.4B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.97M
Exchange
NGM
Currency
USD
52-Week Range
Low $4.83Current $8.820High $11.775
Related News
GlobeNewswire
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular's first registrational trial in wet AMD, completed randomization in December 2024 and retention
View more
Related Stocks
ZUO
Zuora Inc.
NASDAQ
Computer Softwa...
PACK
Ranpak Holdings Corp
NASDAQ
Containers/Pack...
CVAC
CureVac N.V. Ordinary Shares
NASDAQ
Biotechnology: ...
ETB
Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund Common Shares of Beneficial Interest
NASDAQ
Investment Bank...
RVLV
Revolve Group Inc.
NASDAQ
Catalog/Special...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.